(PharmaNewsWire.Com, July 06, 2017 ) Hormone Replacement Therapy (also known as menopausal hormone therapy, hormone therapy, and estrogen replacement therapy) uses female hormones -- estrogen and progesterone -- to treat common symptoms of menopause and aging. Nowadays, hormone therapy is even employed in treatment of other conditions like Male Hypogonadism, Growth Hormone Deficiency, and Hypothyroidism etc. The Latin America Hormone Replacement Therapy Market is estimated at USD 1.58 billion in 2016 and is predicted to reach USD 2.29 billion by 2021, growing at a CAGR of 7.75%.
The key growth driver of the Latin America hormone replacement therapy market is the increasing awareness about post-menopausal problems amongst women. The other noteworthy growth drivers are availability and development novel formulations, presence of unmet medical needs which require the employment of hormone therapy.
However, based on research studies, hormone replacement therapy can cause severe side effects, such as bleeding, breast tenderness or enlargement, bloating, mood changes, headaches, and nausea, risk of breast cancer, heart disease, and stroke. Along with this, high cost of therapy is limiting its reach to middle class people. Further, women with high susceptibility to coronary diseases are advised to stay away from hormone replacement therapy thereby decreasing the size of target audience.
The Latin America hormone replacement therapy is segmented on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. The estrogen replacement therapy is the major segment as its employed by majority women to treat menopause, and is followed by growth hormone replacement therapy. Further, on the basis of route of administration the market is classified as oral, transdermal, parenteral, and other routes. Morover, on the basis of geography, the Latin America hormone replacement therapy market is analysed under Brazil, Argentina and Mexico countries. Brazil being the 9th largest and one of the fast-growing economy in the world, dominates the market in this region owing to the economic conditions, awareness among women.
Some of the key players operating in the Latin America hormone replacement industry are Novartis, Pfizer, Mylan Laboratories, Abbott Laboratories, F. Hoffmann-La Roche, Merck & Co., Amgen, Eli Lily, Bayer,and Novo Nordisk
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
